Assessing reperfusion with whole-brain arterial spin labeling: a noninvasive alternative to gadolinium

Raymond V Mirasol1, Reinoud P H Bokkers, Daymara A Hernandez

  • 1From the Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD (R.V.M., D.A.H., J.G.M., M.L., S.W., L.L.L.); Department of Neurobiology, Care Sciences and Society, Division of Neurodegeneration, The Karolinska Institute, Stockholm, Sweden (R.V.M.); Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands (R.P.H.B.); Department of Radiology, Gelre Hospitals, Apeldoorn, The Netherlands (R.P.H.B.); Research Scholars Program, Howard Hughes Medical Institute, Bethesda, MD (R.V.M.); Department of Neurology and Neurotherapeutics, Seton/UT Southwestern Clinical Research Institute of Austin, UT Southwestern Medical Center, TX (S.W.); and Johns Hopkins Community Physicians, Bethesda, MD (J.G.M.).

Stroke
|January 4, 2014
PubMed
Abstract